SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MERIGHI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.734
EU - Europa 3.907
AS - Asia 2.573
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 7
SA - Sud America 6
AF - Africa 2
Totale 19.236
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.719
CN - Cina 1.450
UA - Ucraina 961
DE - Germania 885
IT - Italia 689
TR - Turchia 683
GB - Regno Unito 383
SE - Svezia 333
SG - Singapore 308
FI - Finlandia 213
PL - Polonia 155
RU - Federazione Russa 121
FR - Francia 57
HK - Hong Kong 49
BE - Belgio 24
ID - Indonesia 24
NL - Olanda 24
CZ - Repubblica Ceca 19
ES - Italia 17
VN - Vietnam 13
IN - India 11
CA - Canada 10
IR - Iran 7
AU - Australia 6
EU - Europa 6
JP - Giappone 6
IL - Israele 5
MX - Messico 5
AT - Austria 4
CL - Cile 4
CH - Svizzera 3
HU - Ungheria 3
KR - Corea 3
MY - Malesia 3
RO - Romania 3
TW - Taiwan 3
BD - Bangladesh 2
DZ - Algeria 2
GR - Grecia 2
IE - Irlanda 2
IM - Isola di Man 2
IQ - Iraq 2
NO - Norvegia 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
HR - Croazia 1
ME - Montenegro 1
NZ - Nuova Zelanda 1
RS - Serbia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 19.236
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.755
Fairfield 1.554
Jacksonville 1.091
Chandler 1.076
Houston 1.036
Ann Arbor 878
Ashburn 762
Seattle 649
Wilmington 639
Cambridge 532
Izmir 364
Nanjing 334
Beijing 295
Ferrara 264
Princeton 255
Boardman 196
Singapore 180
Milan 168
Warsaw 154
Shanghai 139
Dearborn 126
San Diego 114
Shenyang 110
Nanchang 105
Addison 90
Bremen 82
New York 74
Hebei 64
Tianjin 64
Changsha 61
Hong Kong 48
Jiaxing 45
San Mateo 43
Jinan 41
Falls Church 39
Mountain View 35
Kunming 34
Norwalk 32
Zhengzhou 31
Los Angeles 27
Auburn Hills 26
Redwood City 25
Jakarta 24
Ningbo 24
Brussels 23
Philadelphia 23
Chicago 20
Des Moines 20
London 20
Orange 19
Guangzhou 18
Lanzhou 16
Tappahannock 14
Bologna 13
Hefei 13
Verona 13
Washington 13
Dong Ket 12
Ferrara di Monte Baldo 12
Hangzhou 12
Redmond 12
Taizhou 12
Brno 11
Indiana 10
Helsinki 9
Meppel 9
Otura 9
Rome 9
Haikou 8
Augusta 7
Düsseldorf 7
Reggio Emilia 7
Edinburgh 6
Hounslow 6
Kilburn 6
Padova 6
Florence 5
Frankfurt am Main 5
Genoa 5
Venice 5
Amsterdam 4
Ardabil 4
Montreal 4
Munich 4
New Bedfont 4
Olomouc 4
Pune 4
San Francisco 4
Tel Aviv 4
Adelaide 3
Bari 3
Budapest 3
Calderara Di Reno 3
Camerino 3
Changchun 3
Clifton 3
Istanbul 3
Kuala Lumpur 3
Lappeenranta 3
Lequile 3
Totale 14.169
Salva come PNG Salva come JPEG
Nome #
A glance at adenosine receptors: Novel target for antitumor therapy 193
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 187
The A3 adenosine receptor: history and perspectives 160
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 153
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 153
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 151
Pharmacology of Adenosine Receptors: The State of the Art 148
Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists 146
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 145
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 142
Pathological overproduction: the bad side of adenosine 140
Adenosine receptors and human melanoma 137
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 133
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 133
Adenosine receptor targeting in health and disease 131
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 128
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 127
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 126
null 125
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 124
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 120
Adenosine receptors and cancer 120
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 120
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 119
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 118
null 118
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 118
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 118
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 117
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 117
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 116
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 114
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 114
null 113
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 113
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 113
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 112
null 112
New potent and selective human adenosine A3 receptor antagonists. 112
The A3 adenosine receptor: an enigmatic player in cell biology. 111
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 111
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 111
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 110
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 110
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 109
Agonists and antagonists: Molecular mechanisms and therapeutic applications 109
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 108
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects. 108
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 107
null 107
Adenosine receptors in health and disease 107
Novel selective antagonist radioligands for the pharmacological study of A2B adenosine receptors 106
A(2A) adenosine receptors in human peripheral blood cells 106
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 106
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 106
null 106
Binding thermodynamics at the human cannabinoid CB1 and CB2 receptors 105
Expression, pharmacological profile and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells by using a novel selective antagonist radioligand, [3H]MRE2029F20. 105
Adenosine and lymphocyte regulation 105
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line. 104
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors: functional and biochemical aspects 104
Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line 104
Hydrogen sulfide modulates the release of nitric oxide and VEGF in human keratinocytes. 104
van't Hoff Based Thermodynamics 104
Synthesis and activity of 3-pyridylamine ligands at central nicotinic receptors 103
HIF-1 neuroprotection through erythropoietin increase in hypoxia: a role for A1 adenosine receptors 103
Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells 103
null 102
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: A pharmacological and biochemical study. 102
null 102
Adenosine A2A receptors in human circulating blood elements 101
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells. 101
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 101
Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A(2B) adenosine receptor antagonists 100
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 100
Synthesis and preliminary biological evaluation of [H-3]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A(3) adenosine receptors 99
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 99
THERMODYNAMICS OF A2B ADENOSINE RECEPTOR BINDING DISCRIMINATES AGONISTIC FROM ANTAGONISTIC BEHAVIOUR 99
PKCε as a novel promoter of skeletal muscle differentiation and regeneration 99
Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells 98
Biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptors 97
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 97
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 96
Pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine ligands, new tools to characterize A(3) adenosine receptors in human tumor cell lines 95
[H-3]-MRE 2029-F20, a selective antagonist radioligand for the human A(2B) adenosine receptors 95
Synthesis, molecular modeling and SAR study of novel pyrazolo[5,1-f][1,6]naphthyridines as CB2receptor antagonists/inverse agonists 95
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 93
Glucocorticoids' pharmacology: Past, present and future 93
New potent and selective human adenosine A3 receptor antagonists 93
Pyrazolotriazolopyrimidine derivatives sensitize melanoma cells to the chemiotherapic drugs: taxol and vindesine. 91
Synthesis and binding of 3-aminopyridine derivatives at central nicotinic receptors 91
Dose and time effects of caffeine intake on human platelet adenosine A2A receptors. functional and biochemical aspects 90
null 90
null 90
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 89
null 89
[3H]-MRE 2029-F20, a novel selective antagonist radioligand, for the pharmacological and biochemical characterization of A2B receptors. 89
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 88
Deregulation of Adenosine Receptors in Psoriatic Epidermis: An Option for Therapeutic Treatment 88
Design, synthesis, and biological evaluation of C-9- and C-2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidines as new A(2A) and A(3) adenosine receptors antagonists 87
Totale 11.207
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.099
Totale 78.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.010 688 116 106 544 246 494 379 417 319 433 207 61
2020/20213.065 281 309 129 367 149 325 118 343 64 454 369 157
2021/20222.157 45 228 152 75 84 97 81 104 76 183 322 710
2022/20232.535 245 223 91 337 424 325 140 203 291 24 143 89
2023/20241.272 113 168 44 27 131 139 53 93 32 54 65 353
2024/2025104 104 0 0 0 0 0 0 0 0 0 0 0
Totale 19.537